, Farrah A. Lenard,,
Brian T. Matthews, and Michael T. Beck,
University of Wisconsin-La Crosse, La Crosse, Wisconsin 54601
Received 16 August 2001/ Returned for modification 4 October 2001/ Accepted 30 November 2001
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Bacterial colonization and growth in a urinary tract bathed with urine are important in the disease process. Adherence to uroepithelial cells is a critical step in the ability of bacteria to cause infections. A variety of fimbriae that allow the bacteria to mediate this adherence are expressed by UPEC strains (34). One prevalent variety of fimbriae produced by UPEC strains is the type 1 fimbriae that recognize mannose receptors. More than 85% of E. coli strains possess the genetic information for type 1 pilus expression (8, 51), and more than 70% of E. coli strains express type 1 pili on their surfaces (37).
Several fim genes are involved in the production of type 1 pili. Expression of type 1 pili is mediated by a process called phase variation, where the bacteria can switch between piliated and nonpiliated states (18). Phase variation of type 1 pili is controlled by a site-specific recombination system that determines the orientation of a 314-bp invertible DNA element (1). This invertible element contains the promoter for the fimA structural gene and is flanked by inverted repeats. Two recombinases are responsible for inversion of the invertible element; these enzymes, FimB and FimE (38, 45, 46), belong to the Int class of recombinases (13, 20). The FimB recombinase facilitates switching from phase-off to phase-on, as well as switching from phase-on to phase-off, whereas previously FimE was thought to cause only switching from phase-on to phase-off. Recent studies have suggested that FimE may naturally initiate limited switching from phase-off to phase-on (67) or that this may be possible following amino acid substitution (65). Other cofactors, including integration host factor (13, 20), leucine-responsive protein (6, 23, 57), and the histone-like protein H-NS (11, 35, 53), are also involved in the switching mechanism.
Previous studies on the regulation of type 1 pilus expression have included testing the modulating effect of temperature (7, 14, 23, 54), static broth growth compared to agar growth (17, 23, 31, 52, 63, 64), stationary phase growth (16), glucose effects (19), and the addition of aliphatic amino acids (24, 57) but not pH; the effect of osmolarity has been studied only to a limited degree (41). Phenotypic studies have also been performed with urea (49) and urine (40, 49). There has been no previous examination of fim gene regulation in growth media in which pH fluctuations have been combined with osmotic differences.
In this study, we attempted to answer the following three questions. Do pH, osmolarity, and human urine affect the transcription of key fim genes? If transcriptional regulation does occur, does this regulation affect the position of the invertible element? And do H-NS and OmpR contribute to this regulation under these specific growth conditions? We obtained evidence that pH and osmotic changes in growth media have minor effects on fim gene expression when they are examined individually. However, a low pH combined with a high osmolarity appears to have a synergistic effect manifested by significant repression of fimA and fimB transcription, biasing the invertible element in the phase-off position and resulting in a loss of type 1 pili on the surface of the bacteria.
| MATERIALS AND METHODS |
|---|
|
|
|---|
fim operon
lac operon strain AAEC189 (5) was supplied by Ian Blomfield, Wake Forest University. Transformations were initially done in E. coli strain DH5
(Gibco/BRL, Gaithersburg, Md.), and subsequent ß-galactosidase assays were performed with this strain, as well as with strain AAEC189. The unmarked ompR mutant strain MH1160 (26) and wild-type strain MC4100 were gifts from Linda Kenney, Oregon Health Sciences University. The hns mutant strain RR1 bglY and parental strain RR1 were provided by Staffan Normark, Karolinska Institute. Plasmids pPR274, pPP2-6, pBB2-1, pP5-48, pAON-1, and pUTE1 were supplied by James Duncan. The pUJ8 and pUT-Tc plasmids (10) were gifts from Kenneth Timmis. All of the wild-type E. coli strains were grown in Luria-Bertani (LB) broth at 37°C or were passaged on LB agar plates incubated at 37°C. For recombinant E. coli strains, antibiotics (all obtained from Sigma Chemical Co., St. Louis, Mo.) were used at the following concentrations: ampicillin, 100 µg/ml; chloramphenicol, 12.5 µg/ml; and tetracycline, 10 µg/ml.
|
. Plasmid DNA from this strain was isolated with a commercial kit (Qiagen, Valencia, Calif.) and was used to transform E. coli strain AAEC189 (59). Transformants were selected on LB agar containing chloramphenicol. Transformants were confirmed by plasmid isolation and restriction endonuclease digestion (59). Since plasmid pBB2-1 has a functional invertible element and intact fimB and fimE genes, the invertible element can flip from the phase-on position to the phase-off position and vice versa. Transcription of fimA fused to lacZYA reflects the position of the invertible element.
For construction of the fimB promoter-containing plasmid, we used the pP5-48 plasmid generated by Margaret Pearle, Northwestern University, as a template. Plasmid DNA was isolated from DH5
/pP5-48 cells as described above and was digested with restriction endonuclease NotI. The proper fragment was separated on a low-melting-point agarose gel and processed as previously described (64). This fragment contained the fimB promoter linked to a promoterless lacZ gene from pUJ8. Using this fimB promoter fragment, we ligated (62) this fragment and NotI-digested pPP2-6, a single-copy plasmid derived from pPR274 that contains a multiple cloning site (48). The ligated DNAs were used to transform DH5
cells, and the transformants were selected on LB agar plates containing chloramphenicol and were screened for the fimB-lacZ fusion by using 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal). The colonies that were Cmr and blue were processed further. After confirmatory tests were performed, plasmid pJB5A (fimB-lacZ) was used for the remaining tests. DNA from pJB5A was used to transform E. coli strain AAEC189.
To create the fimE-lacZ fusion on a single-copy plasmid, the pUTE1 plasmid constructed by Margaret Pearle was used. This plasmid has a fimE-lacZ fusion inserted into a mini-Tn5 transposon on a multicopy plasmid. Plasmid DNA was isolated from DH5
/pUTE1 cells and cut with NotI. The correct DNA fragment was isolated and processed as desribed above. This DNA fragment contained the fimE promoter linked to a promoterless lacZ gene from pUJ8. With this DNA fragment, ligation to NotI-digested pPP2-6 DNA was carried out, and then DH5
cells were transformed with the ligated material. Transformants were selected on LB agar containing chloramphenicol and X-Gal. Any blue colonies that arose on the plates were processed further. From this screening process plasmid pJLE4-3 (fimE-lacZYA) was selected and used for the remaining tests. DNA from pJLE4-3 was used to transform E. coli strain AAEC189.
Construction of a recombinant plasmid with the promoter locked in the phase-on position began with plasmid DNA from pAON-1 generated by Margaret Pearle. Plasmid DNA was isolated as described above, digested with NotI, and ligated to NotI-cut pPP2-6 DNA. DNA was transformed into DH5
cells, and transformants were selected for and screened as described above. From this screening process plasmid pWS124-17 (fimA-lacZ locked in the phase-on position) was selected and used for the remaining tests. DNA from pWS124-17 was used to transform E. coli strain AAEC189.
The fimB-lacZ and fimE-lacZ fusions integrated into the chromosome of strain AAEC189 were constructed as follows. Plasmid pP5-48 (fimB-lacZ) DNA was digested with NotI and ligated to NotI-digested pUT-Tc (10) DNA. The resulting plasmid, pUTE4, was transformed into S17.1
pir cells. Then S17.1
pir/pUTE4 cells and AAEC189 cells were conjugated. Transconjugants that were tetracycline resistant and blue on X-Gal-containing media were selected. One of these transconjugants, AAEC189-4fimB, was used to test environmental conditions. To construct the fimE-lacZ fusion in the genome of strain AAEC189, plasmid DNA from pUTE1 was processed as the fimB-lacZ fusion was processed. The resulting plasmid, pUTE4, was transformed into S17.1
pir cells and then mated with strain AAEC189 cells. From this conjugation strain AAEC189-2fimE was chosen and used for further analysis.
Environmental conditions. To obtain variations in pH in vitro, the pH of LB medium was adjusted by using 0.1 M Na2HPO4-NaH2PO4 buffer combined with 1% (vol/vol) glycerol. We prepared a series of LB media with pHs between 5.0 and 8.0 at 0.5-pH unit increments, and the pH values were confirmed with a pH meter (Orion Research). To each aliquot of LB medium 100 µl of a culture of AAEC189 carrying fim-lacZ recombinant plasmids was added. The cultures were incubated overnight at 37°C with shaking. The next day the pHs of the cultures were checked, and a 100-µl aliquot of each culture was transferred to another portion of the same LB medium. The resulting cultures were then incubated with shaking at 37°C, ß-galactosidase assays were performed, and the final pHs were determined.
The osmolarity of Luria broth was adjusted by adding NaCl to final concentrations of 100, 200, 400, and 800 mM. The incubation conditions were the same as those described above. Combinations of different osmolarities and different pHs were also tested by using pHs 5.5 and 7.0 with the same NaCl concentrations.
Bacterial cultures grown in LB medium supplemented with human urine or in pure human urine were also tested. Clean-catch midstream urine samples were collected at different times from a healthy male, and the pH was monitored with a pH meter. Aliquots of the urine were plated onto brain heart infusion agar (Difco) to check for sterility. The urine was added to pH 5.5 LB medium at concentrations of 10, 20, 40, and 80%. Recombinant bacterial cultures were inoculated into the broth media and incubated as described above. To test pure human urine, the pHs of aliquots of fresh human urine obtained from one urine specimen were adjusted to 5.5, 6.0, 6.5, and 7.0 by using the sodium phosphate buffer mentioned above without added glycerol. The urine samples having different pHs were each divided into two portions in order to perform tests on two separate days.
ß-Galactosidase assays. The ß-galactosidase activity of mid-logarithmic-phase bacteria permeabilized with sodium dodecyl sulfate and CHCl3 was determined by using the method of Miller (47). Measurements were obtained after 20 min of exposure to the substrate. Most assays were performed at least three times on different days, and the data were expressed as means ± standard deviations based on the values obtained; the only exception was the analysis of the recombinant strains in pure human urine, for which only two assays were performed on separate days.
Extraction of total RNAs and conversion to cDNAs. Total RNAs were extracted from NU149 cells grown in pH 7.0 low-osmolarity LB medium, in pH 5.5 low-osmolarity LB medium, and in pH 5.5 high-osmolarity (400 mM NaCl) LB medium by using the hot phenol extraction procedure utilized previously (63). The cDNAs used for PCR amplification were each synthesized from 6 µg of total RNA as previously described (62) by using the random hexamer primer from a reverse transcription (RT)-PCR kit (Stratagene, La Jolla, Calif.).
Limiting-dilution PCR analyses. Chromosomal DNAs from E. coli strain NU149 grown in pH 7.0 LB medium containing no added NaCl, in pH 5.5 LB medium containing no added NaCl, and in pH 5.5 LB medium containing 400 mM NaCl were extracted by using a commercial DNA extraction kit (AGTC, Gaithersburg, Md.). The DNA concentrations were standardized, and the preparations were used for PCR amplification as described by Schwan et al. (63) with the INV-FIMA primer pair to amplify the phase-on orientation of the invertible element and the FIME-INV primer pair to amplify the phase-off orientation of the invertible element. The chromosomal DNAs were each serially twofold diluted in double-distilled H2O to a dilution of 1/256, and an aliquot of each dilution was then amplified. PCR amplification was performed at least three times with at least two separate chromosomal DNA preparations for each type of growth conditions.
LD-RT-PCR analyses. Limiting-dilution RT-PCR (LD-RT-PCR) amplification was performed as previously described (66), with the following modifications. A Perkin-Elmer 2400 thermocycler was used under the following PCR conditions: initial denaturation at 94°C for 5 min; 33 cycles consisting of denaturation at 94°C for 1 min, annealing at 57°C for 1 min, and elongation at 72°C for 1 min; and 10 min of elongation at 72°C after the last cycle. The following primers were used: FimB1 (5' CGAATCACTCCTTAAAGCAGC 3'), FimB2 (5' GGCGTAACATGTGCGGATGAA 3'), FimE1 (5' CTGTTGGCATATCGGCATGGG 3'), FimE2 (5' TCGATGCCCGAGATAATCCTGA 3'), EcFtsZ1 (5' TAGCGGTATCACCAAAGGACT 3'), and EcFtsZ2 (5' GTGATCAGAGAGTTCACATGCT 3'). The fimB and fimE primers were derived from the sequence described by Klemm (38), and the ftsZ primer pair was derived from the E. coli genome sequencing project (4). LD-RT-PCR amplification was performed at least three times with cDNAs derived from at least two separate total RNA extractions for each type of culture conditions tested.
EIAs. Bacterial strains were transferred to the appropriate broth cultures and incubated overnight at 37°C with shaking. Then each of the strains was passaged a second time in the same medium overnight at 37°C with shaking. We used agar-grown cultures from serially agar-passaged cultures that have been shown previously to become nonpiliated (31). For all cultures, the optical density at 600 nm was adjusted to 0.800, and 500-µl aliquots of each culture were transferred to 1.5-ml microcentrifuge tubes. The enzyme immunoassay (EIA) procedure described by Hultgren et al. (29) was used. EIAs were performed at least twice for each type of conditions tested, and the values given below are means.
HA assays. Hemagglutination (HA) assays were performed for each culture as previously described (31). These assays were repeated three or four times.
Statistics.
Student's t test was used for statistical analyses. P values of
0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
and AAEC189 (
fim operon). Single-copy plasmid pPR274 has been used previously for this purpose (63). Strain AAEC189 was chosen because it lacks the fim and lac genes. First, the pH of LB medium was adjusted to 5.0 to 8.0 by using NaPO4 buffering and glycerol to maintain the pH. The resulting media were inoculated with strain AAEC189 containing the recombinant single-copy plasmids, and the ß-galactosidase activities of mid-logarithmic-phase cells were determined. The pH of each medium was measured before and after growth to ensure that the pH did not change. We found that the pH before growth and the pH after growth differed by no more than 0.04 unit (data not shown). The optimal pH for expression from all of the fim promoters was found to be pH 7.0 (fimA, 50 Miller units; fimB, 300 Miller units; fimE, 161 Miller units), but the values varied less than threefold over the pH range (Fig. 1A). Incremental increases at pHs greater than 7.0 resulted in slight decreases in activity for all three fim promoters, which were not significant. Moreover, a shift to an acidic pH resulted in decreases in activity for all three promoters, with the greatest decrease occurring as the pH fell to 5.0 (fimA, 16 Miller units; fimB, 162 Miller units; fimE, 95 Miller units). For all three promoters, these changes were significant (fimA, P < 0.003; fimB, P < 0.0003; fimE, P < 0.0004). However, the cultures grown at pH 5.0 grew poorly. The pH 5.5 cultures were able to reach almost the same turbidity as the pH 7.0 cultures. The ß-galactosidase activities were significantly lower at pH 5.5 than at pH 7.0 (fimA, 25 Miller units [P < 0.008]; fimB, 162 Miller units [P < 0.002]; fimE, 95 Miller units [P < 0.03]). These results indicate that pH alone had a minor effect on expression of the fim promoters.
|
[data not shown]), which was significant (P < 0.0007). Even with added 400 mM NaCl the fimA promoter (P < 0.009) and fimB promoter (P < 0.009) activities were significantly lower than the activities observed in LB medium without added NaCl. Moreover, the fimE activity was significantly higher (P < 0.0007) in LB medium containing 400 mM NaCl.
Effects of pH and osmotic conditions together on expression of the fim genes.
As described above, changing the pH or osmolarity had modest effects on expression of the fim genes. Because there are environments in which fluctuations in both pH and osmolarity can occur, such as the human or murine urinary tract, both pH and osmolarity were changed in some experiments. At pH 5.5, the NaCl concentration was changed to values up to 800 mM. In strain AAEC189, the ß-galactosidase activity for fimB (238 Miller units) was approximately twice the ß-galactosidase activity for fimE (116 Miller units) under low-osmolarity conditions (Fig. 1C). When the NaCl concentration was increased by 400 mM (1.2 mol/kg), fimB expression decreased significantly to 112 Miller units (P < 0.0006) and fimE expression increased to 208 Miller units (P < 0.003). When the NaCl concentration was increased to 800 mM (1.8 mol/kg), fimB expression decreased considerably (39 Miller units) (P < 0.00003), whereas fimE expression nearly doubled (218 Miller units) (P < 0.01) compared to the values obtained at pH 7.0 under low-osmolarity conditions. The level of fimA activity decreased almost to the background level in medium containing 400 mM NaCl and to the background level (5 Miller units) under very-high-osmolarity conditions (P < 0.0004). Similar changes were observed for the fim-lacZYA fusions in strain DH5
(data not shown). These results suggest that a low-pH high-osmolarity environment may favor expression of fimE.
Chromosomally integrated fimB-lacZ and fimE-lacZ fusion variants of AAEC189 were also tested under different pH and osmolarity conditions. Strain AAEC189-2fimE grown at pH 7.0 under low-osmolarity conditions had an enzyme activity of 72.6 Miller units; the activity increased slightly to 73.4 Miller units when the NaCl concentration was increased to 400 mM (Table 2). When the pH was 5.5, the activity was 56.6 Miller units, but the activity increased to 62 Miller units when the osmolarity was increased. There was no statistically significnt variation in ß-galactosidase expression in AAEC189 cells grown under these conditions. However, when AAEC189-4fimB was used, there was a significant difference in expression of ß-galactosidase between cultures grown at pH 7.0 (90.6 Miller units) and cultures grown at pH 7.0 with high osmolarity (65.6 Miller units) (P < 0.05). Growth in pH 5.5 medium resulted in 58 Miller units (P < 0.008), and there was an additional decrease in expression in pH 5.5 high-osmolarity medium (49.6 Miller units) (P < 0.002).
|
Urine-containing media and pure human urine affect fim::lacZ expression. Since the fim gene constructs were derived from the J96 UPEC strain (29), we wanted to determine whether growth in human urine could affect expression of the fimA, fimB, and fimE promoters. To elucidate whether human urine itself could have an effect, recombinant AAEC189 bacteria were initially grown in LB media adjusted to pH 5.5 containing different concentrations of filter-sterilized normal male urine; the final pHs were 5.68 to 5.76, and the osmolalities were between 0.78 and 0.90 mol/kg.
For fimA expression, the levels of ß-galactosidase activity were 22.5 Miller units without urine and 14.5 Miller units in the presence of 80% urine (P < 0.09) (Fig. 2A). When the strain was grown in 100% urine, the level of activity was 9 Miller units (data not shown). The results showed that fimB expression decreased approximately twofold (P < 0.0004) when the concentration of urine in the medium was increased to 80% and that fimE expression was constant until 80% urine was present; an approximately 50% increase in fimE expression occurred in the presence of 80% urine (Fig. 2A) (P < 0.04). To further assess the effects of human urine on expression of the fimB and fimE genes, the pH of filtered human urine was adjusted to various values with sodium phosphate buffer, and then the urine was inoculated with strain AAEC189 containing either pJB5A (fimB-lacZYA fusion) or pJLE4-3 (fimE-lacZYA fusion). ß-Galactosidase assays were performed, and the results showed that the fimB levels decreased approximately twofold when the pH was changed from 7.0 to 5.5, whereas the fimE levels remained constant at all pH values (Fig. 2B). These analyses showed that human urine can have effects on fim expression similar to those of low-pH high-osmolarity LB medium.
|
|
|
|
|
|
Osmotic changes in the environment affect supercoiling of the DNA, and they also trigger the EnvZ-OmpR two-component regulatory system in E. coli. To ascertain if the EnvZ-OmpR system is also involved somehow in osmotic regulation of fimB and fimE, an unmarked ompR mutant (26) was transformed with the recombinant fimB-lacZ and fimE-lacZ plasmids and grown in the media described above. Derepression of fimB expression occurred in the ompR mutant strain grown in all of the media tested (Table 5). In the pH 7.0 low-osmolarity medium fimB expression changed from 208 Miller units in the wild-type strain to 283 Miller units in the ompR mutant (P < 0.03). When the NaCl concentration in pH 7.0 medium was increased by 400 mM, the wild-type strain expressed 163 Miller units of activity from the fimB promoter, whereas the ompR mutant expressed 252 Miller units (P < 0.03). As observed for the hns mutant strain, pH had a slight effect on fimB expression in the ompR mutant strain grown at pH 5.5. When the pH of low-osmolarity medium was 5.5, the fimB-lacZ plasmid in wild-type bacteria expressed 119 Miller units of activity, compared to the 151 Miller units of activity observed for the ompR mutant (P < 0.03). After growth in pH 5.5 high-osmolarity medium the wild-type strain exhibited threefold less fimB activity (103 Miller units) than the ompR mutant strain (312 Miller units) (P < 0.0007).
|
| DISCUSSION |
|---|
|
|
|---|
Transcription of all of the fim genes tested (fimA, fimB, and fimE) was maximal at pH 7.0. Alkaline environments had a slight repressing effect on transcription of these fim genes, like the effect observed for the E. coli pap and fan operons (72). A pH of 5.5 or lower also reduced transcription of all of the fim promoters compared to transcription in pH 7.0 medium. In a recent study White-Ziegler et al. (72) demonstrated that growth in pH 5.5 media downregulated pap, daa, and fan pilus operons found in E. coli, suggesting that an acid response global regulator may be involved. The acid tolerance response systems in E. coli include a
s-cyclic AMP receptor-protein system, a glutamate-gamma-aminobutyric acid antiporter, and an arginine-dependent system that requires arginine decarboxylase (22). One or more of these systems may repress transcription of the fim genes. Besides limiting transcription of the fim genes, low-pH environments, particularly human urine (2, 36), may also inhibit the growth of E. coli, and this could help explain the poor growth results obtained for cultures grown at pH 5.0.
Osmolarity was another environmental factor which we examined. Expression of fimA and expression of fimB were maximal in pH 7.0 LB medium without added NaCl, whereas fimE expression was maximal in pH 7.0 LB medium containing 800 mM NaCl. This indicated that single parameters, such as osmotic conditions and pH, had relatively minor effects on transcription of the fim genes. On the other hand, a combination of low pH and moderate to high osmolarity had a profound synergistic effect on fim gene expression, the position of the invertible element, and ultimately expression of type 1 pili on the surfaces of the bacteria. The level of fimB transcription in pH 5.5 medium with 400 mM NaCl was considerably lower than the level of fimB transcription in pH 7.0 medium with low osmolarity, as demonstrated with the fimB-lacZ fusion assays and LD-RT-PCR analysis. Differences between the LD-RT-PCR analysis results and the fim-lacZ reporter fusion analysis results may have been due to the fact that reporter fusions measured transcription over a defined period of time and to the fact that the results did not take into account RNA stability and accumulation that was measured by the LD-RT-PCR. Nevertheless, similar trends were observed when we compared the LD-RT-PCR results to the ß-galactosidase activity results for bacteria grown in the various LB media. A low-pH high-osmolarity environment caused fimE levels to rise and fimB levels to decline. The results obtained with fimB-lacZ and fimE-lacZ fusions integrated into the chromosome of strain AAEC189 supported the single-copy plasmid results, indicating that the use of single-copy plasmids can solve some of the problems in interpretation encountered when multicopy plasmids are used (45, 46).
Since FimB and FimE affect the position of the 314-bp invertible element containing the fimA promoter (45, 46), we predicted that this would have an effect on fimA transcription. Indeed, fimA transcription appeared to be affected based on a shift in the invertible element to the phase-off position in low-pH high-osmolarity conditions rather than on a direct effect on the fimA promoter itself. Ultimately, this led to a decrease in type 1 pilus expression on the bacterial cells as determined by the EIA.
Using different in vitro conditions provided clues about what was happening, but we wanted to know what relevance the results might have for in vivo growth and survival. Experiments performed with urine specimens collected from a single source (pH, around 5.5; osmolarity, 250 to 300 mM [0.8 to 0.9 mol/kg]) substantiated the changes in transcription of the key fim genes when the results were compared to the results obtained with LB media whose pH values and osmolarities were adjusted to various values. Although the use of a single source of urine was a limitation in this study, we found that urine from other individuals did not support the growth of UPEC strains, possibly due to inhibitory agents in the urine samples (data not shown). Thus, there are also inherent dangers in using pooled urine from many individuals. Nonetheless, the bacteria displayed results similar to those obtained with LB medium.
The UPEC strains in the human intestinal tract and in patients with urinary tract infections have been shown to originate from E. coli strains of fecal origin (34). Unsupplemented LB medium has an osmolality similar to the osmolality of the small intestines of mammals (21, 72). Piliated bacteria enter the urethra and move into the bladder, sometimes ascending to the kidneys of an infected host. We used LB medium with 400 mM NaCl (1.2 mol/kg) as the high-osmolarity medium for most of our studies, and this osmolarity was in the normal physiological range for urine in the collecting ducts and Henle's loop within the renal medulla of the human kidney (58) and certainly was in the normal physiological range for the murine kidney (43). Even 800 mM NaCl (1.6 mol/kg) is moderate osmolarity in murine kidneys, in which an osmolality of 3 mol/kg can be reached (43, 61). However, in the human urinary tract, an NaCl concentration of 800 mM is encountered only in a severely dehydrated person on a specific diet, so we performed no further analysis after the initial test under these very high-osmolarity conditions. Instead, we used 400 mM as the highest osmolarity in most of this study.
Osmolarity may affect two systems, the OmpR-EnvZ and H-NS systems. Hyperosmotic conditions trigger the EnvZ protein, an inner membrane histidine kinase osmosensor, which in turn phosphorylates the cytoplasmic DNA-binding protein OmpR (33). At a high osmolarity, there is an increase in the level of phosphorylated OmpR, which in turn binds to DNA sequences to either activate or repress transcription (56). We found that an ompR mutant exhibited threefold derepression of fimB expression in low-pH high-osmolarity growth medium compared to fimB expression in neutral-pH low-osmolarity medium (Table 5); however, fimE expression in the ompR mutant background was not as clear-cut. Wild-type bacteria grown in pH 7.0 low-osmolarity medium had virtually the same ß-galactosidase activity with a fimE-lacZ fusion as bacteria grown in pH 5.5 high-osmolarity medium. This result contrasted with the significantly lower value obtained with cells grown in a pH 5.5 low-osmolarity environment. The divergent effects of OmpR (repressing fimB and possibly neutralizing the repressive effect of an acid response regulator on fimE) favor fimE expression. Based on our data, it appears that FimB is more favored in a neutral-pH low-osmolarity environment and that FimE predominates in a low-pH high-osmolarity environment.
An increase in osmolarity also increases DNA supercoiling (27), providing more curvature to the DNA and more template for the H-NS histone-like DNA-binding protein to bind to (3). The H-NS protein, encoded by the hns gene, is involved in global regulatory events (27, 32, 44). The hns or osmZ gene is allelic to bglY, pilG, and virR (44). Mutations in the hns (pilG) gene affect type 1 pilus expression by causing a higher rate of inversion of the invertible element (35, 66), and fimB transcription is repressed by H-NS (11, 12, 15, 50). Our results support the hypothesis that fimB is derepressed in an hns mutant strain, but there was only a slight effect on fimE expression. Strain differences could explain variations in fimE expression.
Observations made in this study may also help explain murine models of infection that have shown that many E. coli strains become nonpiliated after 5 days in the mouse kidney but remain piliated in the mouse bladder (30, 60). Human or murine kidneys are bathed in urine with higher osmolarity (up to 1.4 mol/kg in humans and 3 mol/kg in mice) and slightly lower pH than the urine in the bladder (43, 58, 61). Moreover, the abundance of mannose receptors in the bladder (51, 71) and the paucity of such receptors in the kidneys (69, 70) may have an effect on expression of both fimB and fimE.
Our hierarchical model for type 1 pilus regulation involves several mechanisms. Within a human or murine kidney, one or more acid adaptation systems and an increase in DNA supercoiling may be triggered in a low-pH high-osmolarity environment, leading to an acid response protein and more H-NS binding to the supercoiled fimB promoter DNA, repressing fimB expression. The EnvZ-OmpR osmolarity sensing system may also be activated, causing either phosphorylated OmpR or an intermediary to bind and repress fimB transcription. If this happens, the level of fimB plummets, so there is limited switching from the phase-off position to the phase-on position. In turn, an acid response system triggers downregulation of fimE that may be countered by slight fimE transcriptional activation by phosphorylated OmpR binding directly to fimE or OmpR acting through an intermediary to activate fimE transcription. More fimE transcription combined with a drastic reduction in the level of fimB transcripts switches the invertible element from the phase-on position to the phase-off position. In this series of events, the invertible element may eventually be locked in the phase-off position. Transcription of fimA would be severely reduced or aborted in this environment, and a nonpiliated phenotype would predominate in time in the kidney.
In the human or murine bladder, an abundance of mannose receptors may circumvent some of the regulatory changes described above. Some recent work has shown that binding of type 1 piliated bacteria to their mannose receptors triggers downregulation of fimE and slight activation of fimB transcription (W. R. Schwan, J. Pinkner, S. J. Hultgren, and M. T. Beck, unpublished data). Urine is slightly less acidic in the bladder than in the kidneys, and the osmolality in the bladder is lower than the osmolality in the kidneys. More FimB and less FimE in the bacteria in the bladder mean that more of the invertible element is in the phase-on position. Recent studies have shown that strains of UPEC from patients are more apt to have the invertible element in the phase-on position when the strains colonize the mouse bladder than when they are grown in vitro (25, 42, 68). Ultimately, fim-reporter fusions in UPEC strains will need to be tested in vivo to ascertain if the observations described above truly reflect what occurs in the murine or human urinary tract.
| ACKNOWLEDGMENTS |
|---|
This work was supported in part by an undergraduate research grant from University of Wisconsin-La Crosse to F.A.L. and by a University of Wisconsin-La Crosse faculty research grant to W.R.S.
| FOOTNOTES |
|---|
Present address: Monsanto, Agracetus Campus, Madison, Wis. ![]()
Present address: Mayo Clinic, Rochester, Minn. ![]()
Present address: Department of Microbiology, Clemson University, Clemson, S.C. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724-5727. |
| 2. | Asscher, A. W., M. Sussman, W. E. Waters, R. H. Davis, and S. Chick. 1966. Urine as a medium for bacterial growth. Lancet ii:1037-1041. |
| 3. | Atlung, T., and H. Ingmer. 1997. H-NS: a modulator of environmentally regulated gene expression. Mol. Microbiol. 24:7-17.[CrossRef][Medline] |
| 4. | Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474. |
| 5. | Blomfield, I. C., M. S. McClain, J. A. Princ, P. J. Calie, and B. I. Eisenstein. 1991. Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J. Bacteriol. 173:5298-5307. |
| 6. | Blomfield, I. C., P. J. Calie, K. J. Eberhardt, M. S. McClain, and B. I. Eisenstein. 1993. Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J. Bacteriol. 175:27-36. |
| 7. | Brinton, C. C. 1959. Non-flagellar appendages of bacteria. Nature 183:782-786.[CrossRef][Medline] |
| 8. | Buchanan, K., S. Falkow, R. A. Hull, and S. I. Hull. 1985. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili. J. Bacteriol. 162:799-803. |
| 9. | Chambers, S., and C. M. Kunin. 1985. The osmoprotective properties of urine for bacteria: the protective effect of betaine and human urine against low pH and high concentrations of electrolytes, sugars, and urea. J. Infect. Dis. 152:1308-1316.[Medline] |
| 10. | de Lorenzo, V., M. Herrero, U. Jakubzik, and K. N. Timmis. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bacteriol. 172:6568-6572. |
| 11. | Donato, G. M., and T. H. Kawula. 1999. Phenotypic analysis of random hns mutations differentiate DNA-binding activity from properties of fimA promoter inversion modulation and bacterial motility. J. Bacteriol. 181:941-948. |
| 12. | Donato, G. M., M. J. Lelivelt, and T. H. Kawula. 1997. Promoter-specific repression of fimB expression by the Escherichia coli nucleoid-associated protein H-NS. J. Bacteriol. 179:6618-6625. |
| 13. | Dorman, C. J., and C. F. Higgins. 1987. Fimbrial phase variation in Escherichia coli: dependence of integration host factor and homologies with other site-specific recombinases. J. Bacteriol. 169:3840-3843. |
| 14. | Dorman, C. J., and N. N. Bhriain. 1992. Thermal regulation of fimA, the Escherichia coli gene coding for the type 1 fimbrial subunit protein. FEMS Microbiol. Lett. 99:125-130.[CrossRef] |
| 15. | Dove, S. L., and C. J. Dorman. 1994. The site-specific recombination system regulating expression of the type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling. Mol. Microbiol. 14:975-988.[Medline] |
| 16. | Dove, S. L., S. G. J. Smith, and C. J. Dorman. 1997. Control of Escherichia coli type 1 fimbrial gene expression in stationary phase: a negative role for RpoS. Mol. Gen. Genet. 254:13-20.[CrossRef][Medline] |
| 17. | Duguid, J. P., W. Smith, G. Dempster, and P. N. Edmunds. 1955. Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli. J. Pathol. Bacteriol. 70:335-348.[CrossRef][Medline] |
| 18. | Eisenstein, B. I. 1981. Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Science 214:347-349. |
| 19. | Eisenstein, B. I., and D. C. Dodd. 1982. Pseudocatabolite repression of type 1 fimbriae of Escherichia coli. J. Bacteriol. 151:1560-1567. |
| 20. | Eisenstein, B. I., D. S. Sweet, V. Vaughn, and D. I. Friedman. 1987. Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc. Natl. Acad. Sci. USA 84:6505-6510. |
| 21. | Ferraris, R. P., S. Yasharpour, K. C. Lloyd, R. Mirzayan, and J. M. Diamond. 1990. Luminal glucose concentrations in the gut under normal conditions. Am. J. Physiol. 259:G822-G837. |
| 22. | Foster, J. W. 1999. When protons attack: microbial strategies of acid adaptation. Curr. Opin. Microbiol. 2:170-174. |
| 23. | Gally, D. L., T. J. Rucker, and I. C. Blomfield. 1994. The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12. J. Bacteriol. 176:5665-5672. |
| 24. | Gally, D. L., J. A. Bogan, B. I. Eisenstein, and I. C. Blomfield. 1993. Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media. J. Bacteriol. 175:6186-6193. |
| 25. | Gunther, N. W., V. Lockatell, D. E. Johnson, and H. L. T. Mobley. 2001. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect. Immun. 69:2838-2846. |
| 26. | Hall, M. N., and T. J. Silhavy. 1981. The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J. Mol. Biol. 146:23-43.[CrossRef][Medline] |
| 27. | Higgins, C. F., C. J. Dorman, D. A. Stirling, L. Waddell, I. R. Booth, G. May, and E. Bremer. 1988. A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell 52:569-584. |
| 28. | Hull, R. A., R. E. Gill, P. Hsu, B. H. Minshew, and S. Falkow. 1981. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect. Immun. 33:933-938. |
| 29. | Hultgren, S. J., J. L. Duncan, A. J. Schaeffer, and S. K. Amundsen. 1990. Mannose-sensitive haemagglutination in the absence of piliation in Escherichia coli. Mol. Microbiol 4:1311-1318.[CrossRef][Medline] |
| 30. | Hultgren, S. J., T. N. Porter, A. J. Schaeffer, and J. L. Duncan. 1985. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect. Immun. 50:370-377. |
| 31. | Hultgren, S. J., W. R. Schwan, A. J. Schaeffer, and J. L. Duncan. 1986. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 54:613-620. |
| 32. | Hulton, C. S., A. Seirafi, J. C. Hinton, J. M. Sidebotham, L. Waddell, G. D. Pavitt, T. Owen-Hughes, A. Spassky, H. Buc, and C. F. Higgins. 1990. Histone-like protein H1 (H-NS), DNA supercoiling, and gene expression in bacteria. Cell 63:631-642.[CrossRef][Medline] |
| 33. | Igo, M. M., A. J. Ninfa, and T. J. Silhavy. 1989. A bacterial environmental sensor that functions as a protein kinase and stimulates transcriptional activation. Genes Dev. 3:598-605. |
| 34. | Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80-125. |
| 35. | Kawula, T. H., and P. E. Orndorff. 1991. Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histone-like protein H-NS. J. Bacteriol. 173:4116-4123. |
| 36. | Kaye, D. 1968. Antibacterial activity of human urine. J. Clin. Investig. 47:2374-2390. |
| 37. | Klemm, P. 1985. Fimbrial adhesions of Escherichia coli. Rev. Infect. Dis. 7:321-340.[Medline] |
| 38. | Klemm, P. 1986. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.[Medline] |
| 39. | Kunin, C. M., and S. T. Chambers. 1989. Osmoprotective properties for bacteria of renal papilla and urine: role of betaines as osmoprotectant molecules, p. 327-332. In E. Kass and C. Svanborg Eden (ed.), Host-parasite interactions in urinary tract infections. University of Chicago Press, Chicago, Ill. |
| 40. | Kunin, C. M., T. H. Hua, L. Van Arsdale White, and M. Villarejo. 1992. Growth of Escherichia coli in human urine: role of salt tolerance and accumulation of glycine betaine. J. Infect. Dis. 166:1311-1315.[Medline] |
| 41. | Kunin, C. M., T. H. Hua, R. L. Guerrant, and L. O. Bakaletz. 1994. Effect of salicylate, bismuth, osmoloytes, and tetracycline resistance on expression of fimbriae by Escherichia coli. Infect. Immun. 62:2178-2186. |
| 42. | Lim, J. K., N. W. Gunther IV, H. Zhao, D. E. Johnson, S. K. Keay, and H. L. T. Mobley. 1998. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect. Immun. 66:3303-3310. |
| 43. | Loeb, W. F., and F. W. Quimby. 1989. The clinical chemistry of laboratory animals. Pergamon Press, New York, N.Y. |
| 44. | May, G., P. Dersch, M. Haardt, A. Middendorf, and E. Bremer. 1990. The osmZ (bglY) gene encodes the DNA-binding protein H-NS (H1a), a component of the Escherichia coli K12 nucleoid. Mol. Gen. Genet. 224:81-90.[CrossRef][Medline] |
| 45. | McClain, M. S., |